Hepoxilin A3 is oxidized by human neutrophils into its ω-hydroxy metabolite by an activity independent of LTB4 ω-hydroxylase

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1348, Issue 3, 1997, Pages 287-298

  Reynaud, Denis ^a   Rounova, Olga ^a   Demin, Peter M ^a,b   Pivnitsky, Kazimir K ^b   Pace Asciak, Cecil R ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hydroxy hepoxilin A3; Oxidation; Hepoxilin A3; Metabolism

Indexed keywords

DRUG METABOLITE; HEPOXILIN A;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; NEUTROPHIL; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0031577649     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(97)00064-7     Document Type: Article

References (24)

1. Pace-Asciak C.R., Granström E., Samuelsson B. J. Biol. Chem. 258:1983;6835-6840.
2. Pace-Asciak C.R. J. Biol. Chem. 259:1984;8332-8337.
3. Reynaud D., Demin P., Pace-Asciak C.R. J. Biol. Chem. 269:1994;23976-23980.
4. Pace-Asciak C.R., Lee W.-S. J. Biol. Chem. 264:1989;9310-9313.
5. Pace-Asciak C.R., Laneuville O., Chang M., Reddy C.C., Su W.-G., Corey E.J. Biochem. Biophys. Res. Commun. 163:1989;1230-1234.
6. Pace-Asciak C.R., Laneuville O., Su W.-G., Corey E.J., Gurevich N., Wu P., Carlen P.L. Proc. Natl. Acad. Sci. USA. 87:1990;3037-3041.
7. Pace-Asciak C.R., Reynaud D., Demin P.M. Lipids. 30:1995;1-8.
8. Pace-Asciak C.R. Biochim. Biophys. Acta. 1215:1994;1-8.
9. Reynaud D., Demin P., Pace-Asciak C.R. Biochem. J. 313:1996;537-541.
10. Reynaud D., Demin P.M., Pace-Asciak C.R. Biochem. Biophys. Res. Comm. 207:1995;191-194.
11. Reynaud, D., Demin, P. and Pace-Asciak, C.R. (1995) in: Mediators in the Cardiovascular System - Regional Ischemia (Schrör, K. and Pace-Asciak, C.R., eds.), Agents and Actions Supplements, Vol. 45, pp. 291-296, Birkhauser Verlag, Basel.
12. Powell W.S. J. Biol. Chem. 259:1984;3082-3089.
13. Soberman R.J., Okita R.T., Fitzsimmons B., Rokach J., Spur B., Austen K.F. J. Biol. Chem. 262:1987;12421-12427.
14. Romano M.C., Eckardt R.G., Benders P.E., Leonard T.B., Straub K.M., Newton J.F. J. Biol. Chem. 262:1987;1590-1595.
15. Demin P.M., Pivnitsky K.K., Vasiljeva L.L., Pace-Asciak C.R. J. Labelled Compounds and Radiopharmaceuticals. 34:1994;221-230.
16. Böyum A. J. Clin. Lab. Invest. 21:1968;77-98.
17. Dho S., Grinstein S., Corey E.J., Su W.G., Pace-Asciak C.R. Biochem. J. 266:1990;63-68.
18. Pace-Asciak, C.R. (1989) Adv. Prostagl. Thromb. Leuk. Res., 18.
19. Demin P.M., Manukina T.A., Pace-Asciak C.R., Pivnitsky K.K. Mendeleev Commun. 4:1996;130-132.
20. Laneuville O., Chang M., Reddy C.C., Corey E.J., Pace-Asciak C.R. J. Biol. Chem. 265:1990;21415-21418.
21. Laneuville O., Corey E.J., Couture R., Pace-Asciak C.R. Biochim. Biophys. Acta. 1084:1991;60-68.
22. Marcus A.J., Safier L.B., Ullman H.L., Broekman M.J., Islam N., Oglesby T.D., Gorman R.R. Proc. Natl. Acad. Sci. USA. 81:1984;903-907.
23. Nadeau M., Fruteau de Laclos B., Picard B., Braquet P., Corey E.J., Borgeat P. Can. J. Biochem. Cell Biol. 62:1984;1321-1326.
24. Kirschner R.H., Getz G.S., Evans A.E. Enzyme. 13:1972;56-76.